logo
Twitter
Discord
Email
logo
National HealthCare Corporation

National HealthCare Corporation

AMEX•NHC
CEO: Dr. Stephen Fowler Flatt
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 1987-01-02
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company's homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, it offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.
Contact Information
100 East Vine Street, Murfreesboro, TN, 37130, United States
615-890-2020
www.nhccare.com
Market Cap
$2.09B
P/E (TTM)
19.9
0
Dividend Yield
1.9%
52W High
$140.41
52W Low
$89.14
52W Range
89%
Rank32Top 16.7%
5.3
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.3 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024

Financial Dashboard

Q3 2025 Data

Revenue

$382.66M+12.48%
4-Quarter Trend

EPS

$2.53-8.99%
4-Quarter Trend

FCF

$56.49M+463.37%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Revenue Growth Strong Net operating revenues reached 1.131B USD, marking a strong 20.6% increase compared to prior nine months period.
Cash Flow Surge Operating cash flow provided 168.271M USD, significantly up 78.0% from the same nine months last year.
Adjusted Profitability Rises Non-GAAP net income grew 47.9% to 75.293M USD, excluding unrealized equity security gains and losses.
Acquisition Accretion Evident White Oak operations contributed 133.606M USD increase in net patient revenues year-over-year comparison.

Risk Factors

NHI Lease Dispute Alleged non-monetary default status on Master Lease with NHI creates material operational uncertainty for facilities.
Liability Reserves Exposure Accrued risk reserves total 114.032M USD, subject to potential adverse adjustment from incurred professional claims.
Regulatory Headwinds Continue Medicare and Medicaid payment changes and interpretations pose ongoing risks to future revenue stability projections.
Labor Cost Pressures Workforce shortages persist, driving up salaries despite agency staffing expense reduction efforts this reporting period.

Outlook

Occupancy Improvement Focus Management prioritizes skilled nursing census, achieving 90.0% average for the third quarter period this year.
Lease Renewal Exercised Option exercised to renew Master Lease with NHI for five years starting January 1, 2027, mitigating immediate risk.
Medicare Rate Increases FY2026 Medicare SNF payments projected for net 3.2% increase effective October 1, 2025, aiding revenue.
Strong Liquidity Position Short-term liquidity supported by 130.629M USD cash and 166.754M USD unrestricted marketable equity securities.

Peer Comparison

Revenue (TTM)

Ardent Health Partners, Inc.ARDT
$6.33B
+10.9%
Select Medical Holdings CorporationSEM
$5.37B
-23.0%
Acadia Healthcare Company, Inc.ACHC
$3.27B
+4.6%

Gross Margin (Latest Quarter)

Acadia Healthcare Company, Inc.ACHC
96.7%
+72.8pp
PROCEPT BioRobotics CorporationPRCT
64.8%
+1.6pp
Ardent Health Partners, Inc.ARDT
57.1%
+13.2pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
BKD$2.56B-8.2-267.9%19.2%
LFST$2.52B-275.0-0.6%22.0%
ADUS$2.09B24.38.5%3.6%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
1.2%
Moderate Growth
4Q Net Income CAGR
86.2%
Profitability Improved
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Next earnings:Feb 25, 2026
|
EPS:-
|
Revenue:-
Reports
All Years
  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 6, 2025|
    Revenue: $382.66M+12.5%
    |
    EPS: $2.53-9.0%
    N/A
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 7, 2025|
    Revenue: $374.91M+28.7%
    |
    EPS: $1.53-12.1%
    N/A
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 8, 2025|
    Revenue: $373.70M+25.7%
    |
    EPS: $2.09+22.2%
    N/A
  • Form 10-K/A - FY 2024

    Period End: Dec 31, 2024|Filed: Mar 3, 2025|
    Revenue: $1.30B+13.7%
    |
    EPS: $6.62+51.8%
    N/A
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 28, 2025|Refer to amended data
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 7, 2024|
    Revenue: $340.20M+17.9%
    |
    EPS: $2.78+308.8%
    Beat
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 8, 2024|
    Revenue: $291.21M+3.1%
    |
    EPS: $1.74+64.2%
    Beat
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 9, 2024|
    Revenue: $297.18M+10.2%
    |
    EPS: $1.71+125.0%
    Meet